ITGAE and neoplasm: Meanwhile, CD103+ tumor-specific CTLs were found to have a markedly higher basal glycolytic rate and elevated maximal glycolytic capacity in terms of cellular energy metabolism, which also contributed to the induction of more effective and faster antitumor efficacy.